↓ Skip to main content

Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature

Overview of attention for article published in Frontiers in oncology, July 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature
Published in
Frontiers in oncology, July 2022
DOI 10.3389/fonc.2022.953149
Pubmed ID
Authors

Vincenzo Nasca, Anna Maria Frezza, Carlo Morosi, Ciriaco Buonomenna, Antonina Parafioriti, Giorgio Zappalà, Federica Bini, Paolo Giovanni Casali, Mattia Loppini, Silvia Stacchiotti

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 13%
Professor 1 13%
Other 1 13%
Student > Master 1 13%
Unknown 4 50%
Readers by discipline Count As %
Unspecified 1 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 13%
Agricultural and Biological Sciences 1 13%
Medicine and Dentistry 1 13%
Unknown 4 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 July 2022.
All research outputs
#8,231,479
of 26,246,850 outputs
Outputs from Frontiers in oncology
#2,996
of 22,949 outputs
Outputs of similar age
#145,635
of 440,149 outputs
Outputs of similar age from Frontiers in oncology
#192
of 1,760 outputs
Altmetric has tracked 26,246,850 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 22,949 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,149 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 1,760 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.